Early Phase Cancer Immunotherapy: Current Cancer Research
Editat de Sandip Pravin Patel, Razelle Kurzrocken Limba Engleză Hardback – 10 noi 2017
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 984.56 lei 38-45 zile | |
| Springer International Publishing – 28 aug 2018 | 984.56 lei 38-45 zile | |
| Hardback (1) | 1072.26 lei 6-8 săpt. | |
| Springer International Publishing – 10 noi 2017 | 1072.26 lei 6-8 săpt. |
Din seria Current Cancer Research
- 5%
Preț: 1099.59 lei - 5%
Preț: 1563.29 lei - 5%
Preț: 1380.40 lei - 5%
Preț: 1062.68 lei - 5%
Preț: 1058.57 lei - 5%
Preț: 1439.00 lei - 5%
Preț: 1063.39 lei - 5%
Preț: 1406.15 lei - 5%
Preț: 686.73 lei - 5%
Preț: 1065.34 lei - 5%
Preț: 1066.95 lei - 5%
Preț: 1080.25 lei - 5%
Preț: 694.17 lei - 5%
Preț: 1259.96 lei - 5%
Preț: 1069.07 lei - 5%
Preț: 694.88 lei - 5%
Preț: 1137.42 lei - 5%
Preț: 876.56 lei - 5%
Preț: 755.28 lei - 5%
Preț: 1562.22 lei - 5%
Preț: 1397.46 lei
Preț: 1072.26 lei
Preț vechi: 1128.70 lei
-5% Nou
Puncte Express: 1608
Preț estimativ în valută:
205.20€ • 215.82$ • 170.93£
205.20€ • 215.82$ • 170.93£
Carte tipărită la comandă
Livrare economică 03-17 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319637563
ISBN-10: 3319637568
Pagini: 331
Ilustrații: XI, 331 p. 24 illus., 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.66 kg
Ediția:1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Seria Current Cancer Research
Locul publicării:Cham, Switzerland
ISBN-10: 3319637568
Pagini: 331
Ilustrații: XI, 331 p. 24 illus., 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.66 kg
Ediția:1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Seria Current Cancer Research
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins.- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy.- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies.- Chapter 4 Radiographic Evaluation of Immunotherapy.- Chapter 5 Cellular Therapy.- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation.- Chapter 7 Early Phase Cancer Immunotherapy.- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators.- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials.- Chapter 10 Thoracic Immunotherapy.
Notă biografică
Razelle Kurzrock, MD, is Senior Deputy Director for Clinical Science, Chief, Division of Hematology & Oncology, Murray Professor of Medicine, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California, San Diego.
Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.
Sandip Patel, MD, is Assistant Professor, Cancer Immunotherapy Program, Experimental Therapeutics (Phase 1 Program), Thoracic Oncology, Division of Hematology & Oncology and Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center.
Textul de pe ultima copertă
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Caracteristici
Focuses on a state-of-the-art review of early phase clinical trials for cancer immunotherapy Discusses about biomarker selection and combinatorial strategies Discusses about safety/toxicity determination of Phase 2 dosing, endpoints in the setting of psuedoprogession and histology selection as they relate to early phase cancer immunotherapy Features chapters written by internationally-known experts in the field